Sugi Holdings Co.,Ltd. (SGIPF)
OTCMKTS
· Delayed Price · Currency is USD
16.29
+16.29 (0.00%)
Jan 24, 2025, 4:00 PM EDT
Sugi Holdings Revenue
In the fiscal year ending February 28, 2025, Sugi Holdings had annual revenue of 878.02B JPY with 17.94% growth. Sugi Holdings had revenue of 243.40B in the quarter ending February 28, 2025, with 25.89% growth.
Revenue
878.02B JPY
Revenue Growth
+17.94%
P/S Ratio
0.67
Revenue / Employee
74.28M JPY
Employees
11,820
Market Cap
3.90B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 878.02B | 133.54B | 17.94% |
Feb 29, 2024 | 744.48B | 76.83B | 11.51% |
Feb 28, 2023 | 667.65B | 42.17B | 6.74% |
Feb 28, 2022 | 625.48B | 22.97B | 3.81% |
Feb 28, 2021 | 602.51B | 60.55B | 11.17% |
Feb 29, 2020 | Pro | Pro | Pro |
Feb 28, 2019 | Pro | Pro | Pro |
Feb 28, 2018 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Northwest Biotherapeutics | 1.47M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |